3/5
08:30 pm
tngx
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
Neutral
Report
Tango Therapeutics (TNGX) Hits All-Time High as Analyst Turns Bullish [Yahoo! Finance]
3/5
08:07 pm
tngx
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Neutral
Report
Tango Therapeutics (TNGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/5
07:29 am
tngx
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
High
Report
Tango Therapeutics GAAP EPS of -$0.29 beats by $0.03, revenue of $0M misses by $0.5M [Seeking Alpha]
3/5
07:00 am
tngx
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
High
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights
3/4
06:48 pm
tngx
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]
High
Report
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing [Yahoo! Finance]
2/23
09:00 am
tngx
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.
Medium
Report
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Mizuho. They set an "outperform" rating and a $19.00 price target on the stock.
2/18
07:00 am
tngx
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
Medium
Report
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
2/15
02:21 pm
tngx
Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat [Yahoo! Finance]
Low
Report
Tango Therapeutics CEO Teases Pivotal Vopimetostat Trial, RAS Combo Data at Guggenheim Chat [Yahoo! Finance]
3/5/2026
07:00 am
TNGX
tango therapeutics, inc.
BEAT
Report
40.3%
tango therapeutics, inc.
11/4/2025
09:00 am
TNGX
tango therapeutics, inc.
BEAT
Report
-2.5%
tango therapeutics, inc.
8/5/2025
07:00 am
TNGX
tango therapeutics, inc.
IN-LINE
Report
7.5%
tango therapeutics, inc.
5/12/2025
07:00 am
TNGX
tango therapeutics, inc.
MISS
Report
18.0%
tango therapeutics, inc.
3/5
04:53 pm
tngx
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
Low
Report
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
3/5
07:31 am
tngx
Form S-8 Tango Therapeutics, Inc.
High
Report
Form S-8 Tango Therapeutics, Inc.
3/5
07:15 am
tngx
Form 8-K Tango Therapeutics, Inc. For: Mar 05
High
Report
Form 8-K Tango Therapeutics, Inc. For: Mar 05
3/5
07:11 am
tngx
Form 10-K Tango Therapeutics, Inc. For: Dec 31
High
Report
Form 10-K Tango Therapeutics, Inc. For: Dec 31
2/27
06:55 pm
tngx
Form 4 Tango Therapeutics, Inc. For: Feb 25 Filed by: Crystal Adam
Medium
Report
Form 4 Tango Therapeutics, Inc. For: Feb 25 Filed by: Crystal Adam
2/25
04:36 pm
tngx
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
Medium
Report
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
2/17
06:30 pm
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: EcoR1 Capital, LLC
Medium
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: EcoR1 Capital, LLC
2/17
04:23 pm
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Medium
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register